Panel: Addressing The Industry’s Challenges with Data Quality, Access & Regulatory Acceptance Across Europe

Time: 9:30 am
day: Day One


  • Exploring the evolving European regulatory framework and its impact on the acceptance of real-world evidence in drug development and clinical trials
  • Addressing data privacy concerns and ensuring compliance with European data protection regulations
  • Manoeuvring methods to break down databases and improve data quality for more effective real-world evidence utilisation

Moderated By: Lene Hammer-Helmich, Director, Head of RWE & Epidemiology, Lundbeck